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Abstract Currarino syndrome (CS) is a peculiar form of
caudal regression syndrome [also known as autosomal
dominant sacral agenesis (OMIM no. 176450)] charac-
terised by (1) partial absence of the sacrum with intact first
sacral vertebra, (2) a pre-sacral mass and (3) anorectal
anomalies (Currarino triad). We studied a 3-year-old girl
with Currarino triad who had additional systemic features
and performed array comparative genomic hybridisation
to look for chromosomal abnormalities. This girl had the
typical spectrum of anomalies of the CS including (a)
partial sacral agenesis (hemisacrum with remnants of only
sacral S1–S2 vertebrae and a residual S3 vertebral body)
associated with complete coccygeal agenesis, (b) pre-
intrasacral dermoid, (c) intra-dural lipoma, (d) ectopic
anus and (e) tethered cord. She had, in addition, pre- and
post-natal growth impairment (<3rd percentile), severe
microcephaly (<−3 SD) with normal gyration pattern and
lack of cortical thickening associated with a hypoplastic
inferior vermis, facial dysmorphism, sensorineural deaf-
ness and decreased serum levels of IGF-1. A de novo
10.3-Mb duplication of 7q34–q35 and an 8.8-Mb deletion
on 7q36 were identified in this patient. The Homeobox
HLXB9 (CS) gene is contained within the deletion
accounting for the CS phenotype including microcephaly.
The spectrums of associated abnormalities in the IGF-1
deficiency growth retardation with sensorineural deafness
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DOI 10.1007/s00431-009-1061-6and mental retardation syndrome (OMIM no. 608747) are
discussed. To the best of our knowledge, this is the first
reported case of a patient with distal 7q chromosomal
imbalance and features of CS triad (including microcephaly)
and the first documented case of a patient with normal
gyration pattern microcephaly. The spectrum of associated
anomalies in this newly recognised phenotype complex
consists of growth failure, typical facial anomalies with
additional (previously unreported) nervous system abnormal-
ities (e.g. sensorineural deafness) and somatomedin C
deficiency.
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Abbreviations
a-CGH Array comparative genomic hybridisation
AMA Anti-muscle antibodies
ANA Anti-nuclear antibodies
ASMA Anti-smooth muscle antibodies
BAC Bacterial artificial chromosomes
CNS Central nervous system
CS Currarino syndrome
ECG Electrocardiogram
EEG Electroencephalogram
ERG Electroretinogram
FISH Fluorescence in situ hybridisation
FSH Follicle-stimulating hormone
FT3 Free thyroxin 3
FT4 Free thyroxin 4
GH Growth hormone
HLBX9 Homeobox gene HB9
IGF-1 Insulin growth factor-1
LH Luteinising hormone
MRI Magnetic resonance imaging
OMIM Online Mendelian Inheritance in Men
PRL Prolactin
S Sacral (vertebrae)
SD Standard deviation
TSH Thyroid-stimulating hormone
Introduction
The caudal regression (or caudal agenesis) syndrome is
classified into two types depending on the shape and
position of the spinal cord terminus: (1) an abrupt and
high type and (2) a tethered and low type (types I and II,
respectively). Caudal regression is one of the major
components of the Currarino syndrome or triad (CS; also
known as autosomal dominant sacral agenesis;O M I M
no. 176450) [6, 13], in which its classic form consists of
(1) partial sacral defects consisting of (partial) sacral
agenesis with an intact first sacral vertebra (hemisacrum or
“sickle-shaped” sacrum), (2) a pre-sacral mass, including
an anterior meningocele, an enteric cyst and/or a pre-
sacral teratoma, and (3) congenital anal stenosis or other
anorectal malformations (such as imperforate anus with/
without anal fistula to the spinal cord or to the urogenital
system) [13, 15].
Currently, CS is regarded as a developmental field
disorder based on its recognised aetiological heterogeneity
and is thought to result from abnormal separation of the
neuroectoderm from the endoderm [9]. In contrast to other
types of partial or total sacrococcygeal agenesis, the sacral
agenesis in CS is typically incomplete and only involves
vertebrae S2–S5, a sacral anomaly distinct to this syn-
drome. CS exhibits variable expressivity, reduced pene-
trance and remarkable variability of objective findings and
subjective complaints, with a clinical spectrum ranging
from anomalies localised only to the caudal region to those
involving complex malformations of other organ systems
including the kidneys, brain and spinal cord [5, 15, 16]. An
X-linked (dominant) pattern of inheritance was proposed,
though more recent reports demonstrate an autosomal
dominant mode of inheritance [1, 8, 9]. CS has recently
been associated with mutations of HLXB9, a homeobox
gene that maps to chromosome 7q36 [12, 13, 21].
We report a case of a patient with features of CS
combined with severe microcephaly, facial dysmorphism,
sensorineural deafness and somatomedin deficiency in
which we found a complex rearrangement of distal 7q that
included deletion of the Homeobox HLBX9 gene. The co-
occurrence of a CS-like phenotype and microcephaly has
been reported in previous patients [11, 17, 20] (Table 1):
Notably, these had a 7q36 deletion with incomplete features
of CS combined with tethered cord (in 2/3) and congenital
ptosis (2/3). One of these patients had features suggesting
the microform of holoprosencephaly [17].
Case report
This 3-year-old girl was the second born to unrelated Italian
parents.
In her family history, there were two previous
miscarriages: one voluntary (due to severe, systemic foetal
malformations) and the other spontaneous (occurred at the
third gestational month). The proband’s father, aged
32 years, has an asymptomatic total posterior sacral canal
schisis; the proband’s sister, aged 5 years, has an
asymptomatic partial schisis of the sacrum canal. In both,
the evaluation for further signs fitting with the CS
phenotype was negative.
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Main features Masuno [17] Rodriguez [20] Horn [11] Present patient
Patient 1 Patient 2
Sex/age F/2.6 yrs M/7.2 yrs M/38 wks M/3.1 yrs F/3 yrs
Pregnancy ––Diabetes
(20–22 wks)
––
Weight (kg) 8.9 (−2.3 SD) 13 (−2.6 SD) 2.8 (25–50th perc) 10 (<3rd perc) 7
Length (cm) 80.5 (−2.3 SD) 95.5 (−5 SD) 46 (10–25th perc) 89 (<3rd perc) 72
Head circumference (cm) 42.2 (−3.7 SD) 44.5 (−5.1 SD) 31.6 (10th perc) 46 (<3rd perc) 39.5 (<3rd perc)
Neonatal period FS (10 mo) pyelonephritis Bacterial
meningitis
Hypotonia, failure
thrive
RD, IAD, DA
Craniofacial
Microcephaly + + + + +
Hypertelorism −−− − +
Hypotelorism + + − + −
Epicanthal folds −−− − +
Hypoplastic eyebrows −−− − +
Coloboma −−− − −
Ptosis −−+++
Depressed nasal root + −− − +
Large ears −−− − +
Low-set hair −−− − +
Midface hypoplasia + + −−−
Choanal narrowing −−− − −
Single central incisors + + −−+
Cleft palate −−− − −
Prominent maxilla [mild micro-retrognathia] −−− − +
Small heart-shaped mouth −−− − +
V-shaped depression (chin) −−− − +
Small hands (short thumbs) −−− − +
Syndactyly −−− − +
Currarino triad
Sacral agenesis (below S1) + + + + +
Pre-sacral tumour −−+ − +
Anorectal malformations −−− − +
Other/systemic
Tethered cord −−+++
Urogenital anomalies + −− − −
Pituitary abnormalities −−− + −
Other brain abnormalities −−hydrocephaly − Hypoplastic vermis
Cytogenetic/FISH 46,XX,del(7)
(pter->q36.1:)
46,XY,del(7)
(pter->q36.1:)
46,XY,del(7)
(q36->qter)
46,XY,del(7)
(q36.1)
46 XY, dup 7q34–q35
(chr7: 138,293,371–
148,443,994)
del 7q36 (chr7:
148,472,027–
157,265,994)
M male, F female, yrs years, mo months, NR not recorded, perc percentile, DA ductus arteriosus, FS febrile seizures, IAD interatrial defect, RD
respiratory distress, S1 1st sacral vertebra, SD standard deviations
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a pregnancy characterised by hyperemesis, repeated threat-
ened abortion, intra-uterine growth retardation and threat-
ened pre-term delivery. The birth weight was 1,740 g, the
birth length was 43 cm, and the head circumference was
28 cm. At birth, she was admitted to a neonatal intensive
care unit elsewhere in Italy because of respiratory distress:
at that time, the heart ultrasound examination revealed a
patent inter-atrial septum and a patent ductus arteriosus.
She was hospitalised for 2 months. After discharge, she was
followed up as an outpatient for psychomotor delay. During
follow-up, she developed frequent episodes of cyanosis and
recurrent respiratory tract infections. An auditory-evoked
potential study revealed moderately severe sensorineural
deafness (66 dB).
At age 18 months, she was admitted to a tertiary care
hospital for a diagnostic work-up. Upon general and
neurological examination, there was severe microcephaly
(head circumference was 38 cm), convergent strabismus
and axial hypotonia; she was unable to sit and did not
vocalise. Chest X-rays, as well as heart and abdominal
ultrasound examinations, was negative. Her bone age
was 8.5 months. On central nervous system magnetic
resonance imaging (MRI), the following features were
recorded: microencephaly with normal gyration pattern,
lack of cortical thickening, normal corpus callosum and
myelination and associated with a hypoplastic inferior
vermis (Fig. 1a, b). An X-ray study of the spine revealed
partial sacrococcygeal agenesis, and the spinal MRI
confirmed the presence of the first two sacral elements
as well as a rudimentary S3 vertebra, whereas the S4 and
S5 vertebras and the coccyx were absent. The spinal cord
was low in position and tethered to an intra-dural lipoma,
w h i c hi nt u r nw a sc o n n e c t e dt oad e r m o i dt h a te x t e n d e d
from the spinal canal to the pre-sacral space (Fig. 1c–f).
To exclude dysganglionosis, a rectal biopsy was per-
Fig. 1 MRI study of the central
nervous system in the proband
(a–f). Sagittal T2-weighted (a)
and axial T2-weighted (b)
images show microcephaly with
normal gyration pattern. Note the
disproportion between the size of
the face and that of the brain (a),
which is a typical feature of
microcephaly. The inferior
cerebellar vermis is hypoplastic
(black arrows; a) with
corresponding enlargement of the
cisterna magna; the lateral ven-
tricles are somewhat dysmorphic
(b). Sagittal T2-weighted (c)a n d
contrast enhanced sagittal T1-
weighted (d)i m a g e so ft h e
lumbosacral spine show partial
sacrococcygeal agenesis with a
rudiment of S3 as final visible
vertebra; the spinal cord is low in
position (arrowhead) and teth-
ered to an intra-dural lipoma (d;
thin white arrow), which in turn
is contiguous with a intra-sacral
mass (a dermoid; c, d; thick
black arrows), which extends
inferiorly around the extremity of
the dysgenetic sacrum; the mass
is very slightly hypointense to
CSF on T2-weighted images (c)
and hyperintense on T1-weighted
images without evidence of con-
trast enhancement (d). Sagittal
diffusion-weighted images (e, f)
with the corresponding ADC
map show restricted diffusion
(arrow), consistent with dermoid
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the patient underwent gastrointestinal surgery (Nissen
fundoplication) for gastroesophageal reflux. At this time,
DNA analysis for the HLBX9 gene mutations was
negative.
The patient was readmitted at age 21 and 24 months
for further diagnostic work-up, and she underwent
surgery for the cord tethering with partial removal of
the spinal masses.
Upon admission at the University Children’sH o s p i t a l
of Catania, at age 28 months, the girl’s general
conditions were fair: her weight was 7 kg, height was
72 cm, and head circumference was 39.5 cm (all below
the third percentile). Her head was extremely small (<−3
SD) with a sloping forehead; she had low-set hair; her
ears were large; there was right palpebral ptosis,
hypothelorism, epicanthal folds and bilateral hypoplasia
of the lateral sides of the eyebrows; her nasal root was
depressed; the maxilla was prominent with mild micro-
retrognathia, and she had a small, heart-shaped mouth
with a V-shaped depression in the chin; the dentition was
normal except for two large maxillary central incisors
(Fig. 2); the hands were small with short thumbs; there
were remnants of a sacrococcygeal tail and partial
syndactyly of the second and third toes bilaterally.
Neurological examination revealed a severely retarded
child with mild generalised muscular hypotonia. She was
unable to vocalise and could not sit, and she kept her feet
in the plantar position. Patellar reflexes were brisk.
Laboratory analysis, including routine serum and
urinalysis, full autoimmune profiles and coagulation
studies, were all within the normal limits. The endocrine
status, including FT3, FT4, TSH, FSH, LH, PRL,
cortisol and GH levels tested from a single blood sample
(without stimulation), were within the normal limits.
IGF-1 levels, tested by ELISA, was 1.2 ng/ml (normal
values for children aged 0 to 5 years of 3.7–150 ng/ml).
Metabolic studies, including plasma ammonia, lactate,
amino acids, serum transferrine (by means of isoelectric
focusing) and urine organic acids, were normal. Electro-
cardiogram, electroencephalogram and heart ultrasound
examination were all normal. Full ophthalmologic exam-
ination was normal. Visual and auditory evoked poten-
tials showed decreased latencies; the electroretinogram
was within normal limits.
Repeated blood and urinalyses, including endocrine
status and IGF-1 levels (in a single blood sample and
without stimulation), at age 36 months, confirmed the
previous findings.
Sequencing of the HLXB9 gene was normal. However,
array comparative genomic hybridisation using a 19 K
BAC array [4, 7] demonstrated a de novo 10.3-Mb
duplication of 7q34–q35 (chr7: 138,293,371–148,443,994)
as well as an 8.8-Mb deletion on 7q36 (chr7: 148,472,027–
157,265,994). Fluorescence in situ hybridisation (FISH)
confirmed the boundaries of the abnormalities, and
microsatellite analysis determined that the abnormalities
occurred de novo on the paternal chromosome. The
deleted region contains 70 RefSeq genes including
HLXB9, SHH and EN2, while the duplication contains
82 genes (Table 1).
Discussion
In our patient, the deletion of HLXB9 must account for
the CS, while loss or gain of other genes probably explains
other aspects of her phenotype [14]. The most striking
components of her phenotype beyond the CS were severe
congenital microcephaly, hypotelorism, cerebellar vermis
hypoplasia and hearing loss. The microcephaly is in the
range seen with autosomal recessive primary microcephaly
or with the severe intra-uterine growth deficiency plus
microcephaly syndrome such as Seckel syndrome. How-
ever, the complex malformation phenotype presented by
our patient did not fit with the above conditions.
Heterozygous loss of SHH is a well-known cause of
holoprosencephaly [19], but many patients with SHH
mutations have less severe phenotypes, often designated
as microforms. Both hypotelorism and congenital micro-
cephaly (usually in the range of −2t o−4 SD) without
holoprosencephaly are well-known microforms associated
with SHH mutations [10, 19], so that loss of SHH could
be likely responsible for all or part of these features. But
the microcephaly in our patient was more severe than
typically seen with SHH mutations, so we suspect a
contribution from one or more other genes or an effect of
Fig. 2 The child at age 3 years: note the two large maxillary central
incisors
Eur J Pediatr (2010) 169:475–481 479the haploinsufficiency for the HLXB9 gene. While no
humans with EN2 mutations have been reported, the
mouse knockout has severe cerebellar hypoplasia [18],
so that deletion of EN2 may at least partly account for the
cerebellar vermis hypoplasia.
Notably, the present child had low IGF-1 levels with
otherwise normal endocrine status (tested in a single blood
sample without stimulation). Decreased IGF-1 levels
(isolated IGF-1 deficiency) is known to produce severe
pre- as well as post-natal growth impairment with other
systemic and neurological abnormalities (OMIM no.
608747; also known as “IGF-1 deficiency, growth retarda-
tion with sensorineural deafness and mental retardation”)
[2, 22] secondary to abnormalities in the IGF-1 gene at
chromosome 12q22-q24.1 (OMIM no. 147440). Woods et
al. [22] reported on a case of a 15-year-old child born of
consanguineous parents affected by this condition: this boy
had severe (pre-natal and post-natal) symmetric growth
failure (which continued throughout infancy and child-
hood), profound bilateral sensorineural deafness and mod-
erately delayed motor development, with behavioural
difficulties including hyperactivity and short attention span
and mild facial dysmorphism. Bonapace et al. [2] reported a
case of a similar patient with IGF-1 deficiency who had
poor foetal growth: this child, who was born to second
cousins both at the fifth percentile for height, continued to
show poor growth and delayed bone age, as well as delayed
psychomotor development and sensorineural deafness. The
patient of Wood et al. [22] placed on recombinant human
IGF-1 treatment improved linear growth and insulin
sensitivity [3, 23].
In summary, the key features in our patient included (1)
type 2 caudal regression consisting of partial sacral agenesis
(presence of only S1–S2 vertebrae and a residual S3
vertebral body) and total coccygeal agenesis; (2) sacral
intra- and pre-canalicular dermoid associated with an intra-
canalicular lipoma and a tethered cord; (3) severe congen-
ital microcephaly (39.5 cm at age 3 years) with a normal
gyral pattern and normal cortical thickness on MRI; (4)
inferior cerebellar vermis hypoplasia; (5) bilateral sensori-
neural hearing loss; (6) facial anomalies including hypo-
telorism, bilateral hypoplasia of the lateral aspect of the
eyebrows, right ptosis, prominent upper mandibula and
normal dentition (besides single central incisors); (7) small
hands with short thumbs; and (8) isolated somatomedin C
deficiency.
To the best of our knowledge, this is the first reported
case of a patient with features of the complete CS triad
and microcephaly. The spectrum of associated anomalies
in this newly recognised phenotype complex consists of
typical facial anomalies with additional (and previously
unreported) nervous system abnormalities (e.g. sensori-
neural deafness). This patient documents the highly
variable nature of this complex anomaly and highlights
its possible link with microcephaly.
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